2001
DOI: 10.1016/s0196-9781(01)00438-7
|View full text |Cite
|
Sign up to set email alerts
|

Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
1
1

Year Published

2003
2003
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(19 citation statements)
references
References 52 publications
1
16
1
1
Order By: Relevance
“…The results of the present study demonstrating an antidepressant-like effect in the forced swim test by SR 142801 are in apparent conflict with another report showing that the NK 3 receptor agonist, aminosenktide, had similar effects in the forced swim test in some mice (Panocka et al, 2001). It is difficult to account for this difference because the mice were selected over 43 generations for differences in opioid-mediated analgesia.…”
Section: Discussioncontrasting
confidence: 99%
“…The results of the present study demonstrating an antidepressant-like effect in the forced swim test by SR 142801 are in apparent conflict with another report showing that the NK 3 receptor agonist, aminosenktide, had similar effects in the forced swim test in some mice (Panocka et al, 2001). It is difficult to account for this difference because the mice were selected over 43 generations for differences in opioid-mediated analgesia.…”
Section: Discussioncontrasting
confidence: 99%
“…Island populations of deer mice, in comparison with mainland conspecifics, display higher opioid-mediated analgesia and lower level of locomotor activity in response to stressors [16]. In agreement with these observations, HA mice, in contrast to LA mice, remain immobile at the beginning of the open field test [2], and at certain swim parameters adopt a passive behaviour, possibly mediated by endogenous opioids [27].…”
Section: Interaction Of Analgesic and Thermoregulatory Mechanisms Dursupporting
confidence: 69%
“…In these areas, NK-3 receptors play a role in pathological inflammatory processes implicated in diseases such as asthma, inflammatory bowel syndrome and cystitis (Canning, 2006; Patacchini and Maggi, 2001). In the central nervous system, their role in modulating dopamine transmission makes them potential targets in treatment of neuropsychiatric illnesses including schizophrenia and various affective disorders, and also Parkinson’s disease (Panocka et al, 2001; Ribeiro and De Lima, 1998; Spooren et al, 2005). Findings from the present study lead us to propose further inquiry into possible consequences of chronic use of agents that function as NK-3 receptor antagonists.…”
Section: Discussionmentioning
confidence: 99%